ArticleCancers2024

A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors.

S Lindsey Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.